The stock market is having a hard time choosing a side after the Fed cut rates
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…
Market rotation winners and losers — plus, quantum computing news from one of our industrials
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…
Meta shares fall on AI restructuring report, while Lilly shrugs off Novo’s Ozempic price move
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…
Eli Lilly and health-care stocks are week’s big winners, 3 sectors fell
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…
An unusual suspect is leading Wednesday’s market while the AI trade takes a breather
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…
Bristol Myers goes DTC on a blockbuster drug. Here’s our take
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…
The Fed’s outlook for inflation and jobs shows the bind it’s in — plus, Amazon’s robotaxi move
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…
Amazon becomes latest tech company to cut back on AI spending — or not
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…